Feedback
Drug Screen (Nonforensic), Serum
0090499
Ordering Recommendation

Detect overdose exposure.

Mnemonic
BLD SCREEN
Methodology
Semi-Quantitative Immunoassay/Gas Chromatography-Mass Spectrometry/ Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-2 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain red. 
Specimen Preparation
Transfer 6 mL serum to ARUP Standard Transport Tubes. (Min: 5.5 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Post-Mortem 
Remarks
Avoid use of separator tubes and gels. 
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 1 week; Frozen: 2 months 
Reference Interval
By report
Interpretive Data
The following drugs or drug classes may be detected: acetaminophen, alcohols, barbiturates, benzodiazepines, carbamazepine, carisoprodol, disopyramide, meprobamate, phenytoin, primidone, salicylate, theophylline, tricyclic and other antidepressants.

Note
This test is not optimized for most drugs of abuse (amphet/methamphet, barbiturates, benzodiazepines, cocaine, methadone, opiates, propoxyphene, PCP, THC); instead, refer to Drug Pan 9, Ser/Pla, Scrn w/Rflx to Conf (ARUP test code 0092420).
CPT Code(s)
Components
Component Test Code*Component Chart NameLOINC
0090499Drug Screen (Nonforensic), Serum20785-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Drug Analysis
  • Multiple Drug Analysis, Blood Screen
  • Tox Screen